Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Dodine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA known ✓ | P21397 | 1/20 | 0.54 |
| ▸ | MAOB known ✓ | P27338 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.95 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.95 |
| ▸ | DHPS | P49366 | 1/20 | 0.58 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.58 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.58 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8818186 | 1.00 | MEN1 (0.95) | MEN1KMT2ADHPSPRSS1PRSS2 | |
| Hydrochloric Acid SCHEMBL5319582 | 1.00 | MEN1 (0.95) | MEN1KMT2ADHPSPRSS1PRSS2 | |
| Hydrochloric Acid SCHEMBL4168696 | 1.00 | MEN1 (0.95) | MEN1KMT2ADHPSPRSS1PRSS2 | |
| Hydrochloric Acid SCHEMBL899169 | 1.00 | MEN1 (0.95) | MEN1KMT2ADHPSPRSS1PRSS2 | |
| Hydrochloric Acid SCHEMBL1123530 | 1.00 | MEN1 (0.95) | MEN1KMT2ADHPSPRSS1PRSS2 | |
| Hydrochloric Acid SCHEMBL27504627 | 1.00 | MEN1 (0.95) | MEN1KMT2ADHPSPRSS1PRSS2 | |
| Hydrochloric Acid SCHEMBL4461585 | 1.00 | MEN1 (0.95) | MEN1KMT2ADHPSPRSS1PRSS2 | |
| SCHEMBL1138747 | 0.97 | MEN1 (1.00) | MEN1KMT2ADHPSPRSS1PRSS2 | |
| SCHEMBL5300899 | 0.97 | MEN1 (1.00) | MEN1KMT2ADHPSPRSS1PRSS2 | |
| SCHEMBL4104867 | 0.97 | MEN1 (1.00) | MEN1KMT2ADHPSPRSS1PRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1720 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122081951-A | Corrosion inhibitor for circulating water of coastal high-chlorine environment steel mill and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| US-20260035753-A1 | METHODS OF DETERMINING BACTERIA AND MANUFACTURING A FIBROUS WEB AND TOOLS AND USES RELATED THERETO | KEMIRA OYJ (FI) | 2026-02-05 | — | — | US | claimed |
| US-12497575-B2 | Fabric softening compositions | COLGATE-PALMOLIVE COMPANY (US) | 2025-12-16 | — | — | US | claimed |
| EP-4105659-B1 | BLOOD CELL LYSIS COMPOSITIONS AND USES THEREOF | INSTR LABORATORY CO (US) | 2025-09-03 | — | — | EP | claimed |
| EP-3707307-B1 | METHOD FOR MANUFACTURING A FIBROUS WEB | KEMIRA OYJ (FI) | 2025-07-23 | — | — | EP | claimed |
| US-12297597-B2 | Cellulose composition | KEMIRA OYJ (FI) | 2025-05-13 | — | — | US | claimed |
| CN-119955274-A | Degradable antibacterial sealing bag and preparation method thereof | 泰州海达塑胶包装有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-119935852-A | Hemolytic agent and detection kit | 深圳市科曼生物医疗有限公司 | 2025-05-06 | — | — | CN | claimed |
| EP-4516862-A1 | AQUEOUS COATING COMPOSITION, COATING OBTAINED FROM THE COATING COMPOSITION, SUBSTRATE CONTAINING THE COATING AND THE USE OF THE AQUEOUS COATING COMPOSITION | DAW SE (DE) | 2025-03-05 | — | — | EP | claimed |
| CN-115804374-B | Sulfate reducing bacteria bactericide and application thereof | 中国石油化工股份有限公司 | 2025-02-21 | — | — | CN | claimed |
| US-5061373-A | Process for treating condensate of steam derived from geothermal brine | UNION OIL COMPANY OF CALIFORNIA (US) | 1991-10-29 | — | — | US | claimed |
| US-5041463-A | Water treatment cooling systems, pulp and papermaking | BETZ LABORATORIES, INC. (US) | 1991-08-20 | — | — | US | claimed |
| US-5032284-A | Process for treating ammonia and nitrite containing waters to prevent nitric oxide emissions therefrom | UNION OIL COMPANY OF CALIFORNIA (US) | 1991-07-16 | — | — | US | claimed |
| US-4906385-A | Method for controlling macroinvertebrates | BETZ LABORATORIES, INC. (US) | 1990-03-06 | — | — | US | claimed |
| EP-0254403-B1 | METHOD FOR CONTROLLING MACROINVERTEBRATES | BETZ EUROPE, INC. (US) | 1990-02-21 | — | — | EP | claimed |
| US-4816163-A | ANTIFOULING AGENTS, MOLLUSKS; ALKYLGUANIDINE SALTS | BETZ LABORATORIES, INC. (US) | 1989-03-28 | — | — | US | claimed |
| EP-0254403-A2 | Method for controlling macroinvertebrates | BETZ EUROPE, INC. (US) | 1988-01-27 | — | — | EP | claimed |
| EP-0254404-A2 | Method for controlling macroinvertebrates | BETZ EUROPE, INC. (US) | 1988-01-27 | — | — | EP | claimed |
| US-4661503-A | WATER TREATMENT | NALCO CHEMICAL COMPANY (US) | 1987-04-28 | — | — | US | claimed |
| US-4455250-A | DODECYLGUANIDINIUM HYDROCHLORIDE | AMERICAN CYANAMID COMPANY (US) | 1984-06-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035753-A1 | METHODS OF DETERMINING BACTERIA AND MANUFACTURING A FIBROUS WEB AND TOOLS AND USES RELATED THERETO | POLL, UROD, RNGTT | MAOA 284/4885MAOB 548/4885MEN1 3227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.